UBQLN4 promotes STING proteasomal degradation during cisplatin-induced DNA damage in triple-negative breast cancer

被引：8
|
作者：
Shoji, Yoshiaki [1 ]
Yokoe, Takamichi [1 ]
Kobayashi, Yuta [1 ]
Murakami, Tomohiro [1 ]
Bostick, Peter J. [2 ]
Shiloh, Yosef [3 ]
Hoon, Dave S. B. [1 ]
Bustos, Matias A. [1 ]
机构：
[1] St Johns Canc Inst, Dept Translat Mol Med, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA
[2] Baton Rouge Gen Med Ctr, Mayo Clin Care Network, Baton Rouge, LA USA
[3] Tel Aviv Univ, Sch Med, David & Inez Myers Lab Canc Genet, Tel Aviv, Israel
来源：
CLINICAL AND TRANSLATIONAL MEDICINE | 2022年 / 12卷 / 07期
关键词：
D O I：
10.1002/ctm2.985
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [31] A novel BRCA1 germline mutation promotes triple-negative breast cancer cells progression and enhances sensitivity to DNA damage agents
    Xu, Kun
    Shi, Yaqin
    Wang, Xin
    Chen, Yajuan
    Tang, Lin
    Guan, Xiaoxiang
    CANCER GENETICS, 2019, 239 : 26 - 32
  • [32] Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells
    Chen, Lian
    Cui, Hengmin
    Fang, Jing
    Deng, Huidan
    Kuang, Ping
    Guo, Hongrui
    Wang, Xun
    Zhao, Ling
    ONCOTARGET, 2016, 7 (34) : 54691 - 54701
  • [33] DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation
    Liu, Jiazhe
    Li, Hongchang
    Mao, Anwei
    Lu, Jingfeng
    Liu, Weiyan
    Qie, Jingbo
    Pan, Gaofeng
    CELL CYCLE, 2020, 19 (24) : 3622 - 3631
  • [34] Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency
    Stecklein, Shane R.
    Barlow, William
    Pusztai, Lajos
    Timms, Kirsten
    Kennedy, Richard
    Logan, Gemma E.
    Seitz, Rob
    Badve, Sunil
    Gokmen-Polar, Yesim
    Porter, Peggy
    Linden, Hannah
    Tripathy, Debu
    Hortobagyi, Gabriel N.
    Godwin, Andrew K.
    Thompson, Alastair
    Hayes, Daniel F.
    Sharma, Priyanka
    JCO PRECISION ONCOLOGY, 2023, 7
  • [35] Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics
    Wang, Nan
    Gu, Yuanting
    Chi, Jiangrui
    Liu, Xinwei
    Xiong, Youyi
    Zhong, Chaochao
    Wang, Fang
    Wang, Xinxing
    Li, Lin
    FRONTIERS IN GENETICS, 2021, 12
  • [36] HSP90 promotes tumor associated macrophage differentiation during triple-negative breast cancer progression
    Hong, Lingjia
    Tanaka, Manami
    Yasui, Masato
    Hara-Chikuma, Mariko
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer
    Zhu, Ying
    Liu, Zhixian
    Gui, Liang
    Yun, Wen
    Mao, Changfei
    Deng, Rong
    Yao, Yufeng
    Yu, Qiao
    Feng, Jifeng
    Ma, Hongxia
    Bao, Wei
    NPJ BREAST CANCER, 2023, 9 (01)
  • [38] Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer
    Ying Zhu
    Zhixian Liu
    Liang Gui
    Wen Yun
    Changfei Mao
    Rong Deng
    Yufeng Yao
    Qiao Yu
    Jifeng Feng
    Hongxia Ma
    Wei Bao
    npj Breast Cancer, 9
  • [39] Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2
    Pan, Teng
    Zhou, Dongdong
    Shi, Zhendong
    Qiu, Yufan
    Zhou, Guanglin
    Liu, Jingjing
    Yang, Qianxi
    Cao, Lixia
    Zhang, Jin
    CANCER LETTERS, 2020, 482 : 102 - 111
  • [40] The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer
    Liu, Hui
    Paddock, Marcia N.
    Wang, Haibin
    Murphy, Charles J.
    Geck, Renee C.
    Navarro, Adrija J.
    Wulf, Gerburg M.
    Elemento, Olivier
    Haucke, Volker
    Cantley, Lewis C.
    Toker, Alex
    CANCER DISCOVERY, 2020, 10 (08) : 1226 - 1239
12345